Aarthi Jayanthan
Geschäftsführer bei Phoenix Molecular Designs Ltd.
Aktive Positionen von Aarthi Jayanthan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Geschäftsführer | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Aarthi Jayanthan
Statistik
International
| Kanada | 2 |
Operativ
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
- Börse
- Insiders
- Aarthi Jayanthan
- Erfahrung
